The first WHO consultation from 6 – 8 October 2020 developed interim guidance of epidemiological and laboratory surveillance of influenza and SARS-CoV-2 using the Global Influenza Surveillance and Response System (GISRS) and associated systems. Since the implementation of the interim guidance, including expediting GISRS genomic surveillance component as part of global efforts, enormous experience has been gained at national, regional and global levels. Meanwhile, the approach of integrated surveillance of influenza and SARS-CoV-2 to address critical public health needs of both influenza and SARS-CoV-2 at the same time using existing systems has been welcome by countries and supported by international agencies.
A year and a half into the COVID-19 pandemic, countries and the world have started building longer-term health emergency preparedness. The low seasonal influenza activity and frequent detections of zoonotic influenza infections are an ominous sign of an impending threat of influenza. It is critical to have a follow up global consultation one year after the 1st consultation to review and address immediate needs and discuss strategy of mid-/long- term development of GISRS.